Serial #79218842
LIVE

Serial Number

79218842

Owner

Angle Europe Limited

Attorney

Christina M. Licursi

Filing Date

Dec 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79218842 Trademark

Serial Number: 79218842 • Registration: 5547884

Serial #79218842 is a trademark filed by Angle Europe Limited on December 21, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Angle Europe Limited

10 Nugent Road,

Entity Type: 99

Trademark Details

Filing Date

December 21, 2016

Registration Date

August 28, 2018

Published for Opposition

June 12, 2018

Goods & Services

[ Medical diagnostic reagents and assay components for testing body fluids, namely, blood and plasma, and cells, all for clinical and medical use; medical diagnostic kits comprised of medical diagnostic reagents and assay components for testing of body fluids, namely, blood and plasma, and cells, for the presence of cancer and other medical disorders for medical purposes and non-pharmaceutical companion medical diagnostics purposes, all the aforesaid goods excluding any such goods that are prescription only pharmaceuticals ]

Biological, [ scientific ] and medical research and consultation services related thereto; [ product research and development in the fields of biology and medical sciences; custom development of biochemical reagents; ] services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; advice and information relating to the aforesaid services

Apparatus, equipment and instruments for scientific, laboratory, non-medical diagnostic or general research use, namely, laboratory analyzers for measuring, testing, and analyzing bodily fluids, blood, plasma, cells, and tissue, pre-packed columns for use in separation and purification, glassware, and tubes in the nature of laboratory storage tubes, namely, sample tubes, reagent tubes, [ phlebotomy tubes and plastic tubes; ] apparatus, equipment and instruments for cytology, histology and for use in detecting medical diseases and disorders, not for medical use, and all for laboratory use, non-medical diagnostic or general research use; apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; laboratory apparatus, namely, cell analyser for providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes for harvesting rare cells therefor; apparatus and equipment for use in testing and analysing tissue, blood, cells and plasma not for medical use, and all for laboratory use, diagnostic or general research use; [ diagnostic reagent kits not for medical use and all for laboratory use consisting primarily of medical diagnostic reagents and assays for use in detecting cancerous conditions and other conditions involving somatic genetic changes; biological analysis computer software; ] structural parts and fitting for the aforesaid goods

Medical diagnostic apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases; medical diagnostic testing apparatus, equipment and instruments for testing in the field of cancer; medical testing kits consisting primarily of medical diagnostic apparatus for testing body fluids, namely, blood and plasma, and rare cells for use in detecting cancerous conditions; structural parts and fittings for the aforesaid goods, namely, medical diagnostic apparatus, equipment and instruments for cytology, histology, and for use in detecting cancer

Diagnostic preparations and reagents for scientific or research use; chemical reagents for non-medical purposes; reagents for in vitro use in biochemistry, clinical chemistry, science and research; chemical preparations, namely, [ buffer solutions and ] reagents for scientific or research use with laboratory apparatus, namely, separation apparatus [ and analysis apparatus; biomarkers, namely, nucleic acids, proteins and other biochemical ligands for scientific or research use; ] chemical test kits for clinical research or medical laboratory use in the detection of cancer and other clinical disorders and diseases, and diagnostic kits comprised of diagnostic reagents and assay components for scientific, research, clinical and medical laboratory use

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
May 7, 2026 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 9, 2026 INPS
INVALIDATION PROCESSED
Apr 9, 2026 INPC
NEW REPRESENTATIVE AT IB RECEIVED
Nov 28, 2025 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 12, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 12, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 12, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 11, 2025 APRE
TEAS SECTION 71 RECEIVED
Aug 22, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 28, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 11, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 11, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jun 23, 2018 GPNX
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 15, 2018 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 12, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 12, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 23, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 23, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 25, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 25, 2018 REAP
REFUSAL PROCESSED BY IB
Nov 17, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 1, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 1, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 28, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 25, 2017 RFCR
NON-FINAL ACTION WRITTEN
Oct 24, 2017 CNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR